Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_assertion type Assertion NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_head.
- NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_assertion description "[Moreover, CD56 expression was significantly associated with P-glycoprotein (PGP) hyperexpression (P = 0.007), unfavorable cytogenetic abnormalities (P = 0.008) and with a reduced probability of achieving complete remission (CR) (36% vs 68%) (P = 0.035) as well as with a shorter survival (6 vs 12 months) (P = 0.032).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_provenance.
- NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_assertion evidence source_evidence_literature NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_provenance.
- NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_assertion SIO_000772 11480556 NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_provenance.
- NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_assertion wasDerivedFrom befree-20150227 NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_provenance.
- NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_assertion wasGeneratedBy ECO_0000203 NP585189.RAF-dBCSoRtHG0_L0Xk3rbzhKIg76oc2XSP-ehOwDiB-s130_provenance.